Get Billing Form

Bristol-Myers Squibb Company (NYSE:BMY) announced today the U.S. Food and Drug Administration (FDA) has approved for the treatment of adults with active Psoriatic Arthritis (PsA)1, a chronic2, inflammatory disease that can affect both the skin and musculoskeletal system.

The cost for intravenous powder for injection 250 mg is around $1,237 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Call 1-800-673-6242 to request an Insurance Benefits Review and Co-pay Card information, or to request an activated Co-pay Card. Patients who have prescription insurance through Medicare may pay $0 to $1,487 per month for . Over 80% of Medicare patients pay $25 or less per month.

DMARDs, or disease-modifying antirheumatic drugs, cost most patients between $1,500 and $2,000 each year, depending on the medication. Biologics, a new type of RA treatment, generally must be given by a health care professional, and they're pricey, running $1,300 to $3,000 per month.

It's important to know that it may take a little while for you to respond to your new treatment. Most patients started feeling better in about 3 to 6 months. Some people see a reduction in signs and symptoms in as early as 2 weeks. Individual results may vary.

The lowest GoodRx price for the most common version of is around $4,586.87, 34% off the average retail price of $7,011.85.

If you don't take it at all: If you don't take this medication your symptoms won't be controlled. You could have worse symptoms, such as bone or joint damage. If you don't take it on schedule: It's important to keep on schedule to ensure that the medication has the same effect on your symptoms and condition.

() is an expensive drug used to treat moderate to severe active rheumatoid arthritis or psoriatic arthritis in adults. This drug is more popular than comparable drugs. There are currently no generic alternatives to .